SHREE GANESH REMEDIES Financial Statement Analysis
|
||
|
The Revenues of SHREE GANESH REMEDIES have increased by 45.26% YoY .
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has increased by 21.86 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SHREE GANESH REMEDIES Last 5 Annual Financial Results
[BOM: 540737]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹71 Cr | ₹49 Cr | ₹5,842,558 Cr | ₹35 Cr | ₹27 Cr |
| Expenses | ₹53 Cr | ₹35 Cr | ₹4,747,824 Cr | ₹27 Cr | ₹22 Cr |
| Operating Profit (Excl OI) | ₹18 Cr | ₹14 Cr | ₹1,094,734 Cr | ₹8.74 Cr | ₹5.19 Cr |
| Other Income | ₹3.57 Cr | ₹2.09 Cr | ₹417,799 Cr | ₹1.17 Cr | ₹1.98 Cr |
| Interest | ₹0.15 Cr | ₹0.07 Cr | ₹14,077 Cr | ₹0.20 Cr | ₹0.10 Cr |
| Depreciation | ₹3.34 Cr | ₹2.73 Cr | ₹224,062 Cr | ₹1.04 Cr | ₹0.60 Cr |
| Profit Before Tax | ₹18 Cr | ₹13 Cr | ₹1,274,393 Cr | ₹8.67 Cr | ₹6.48 Cr |
| Profit After Tax | ₹13 Cr | ₹9.75 Cr | ₹962,453 Cr | ₹6.24 Cr | ₹4.69 Cr |
| Consolidated Net Profit | ₹13 Cr | ₹9.75 Cr | ₹962,453 Cr | ₹6.24 Cr | ₹4.69 Cr |
| Earnings Per Share (Rs) | ₹13.60 | ₹11.16 | ₹9.75 | ₹10.73 | ₹6.95 |
| PAT Margin (%) | 18.87 | 18.80 | 19.87 | 16.47 | 17.66 |
| ROE(%) | 22.62 | 24.02 | 21.18 | 25.35 | 19.95 |
| ROCE(%) | 24.67 | 32.47 | 27.51 | 32.63 | 27.04 |
| Total Debt/Equity(x) | 0.38 | 0.00 | 0.00 | 0.05 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 806.1 Cr |
| Revenue (TTM) | : | ₹ 117.4 Cr |
| Net Profit(TTM) | : | ₹ 22.0 Cr |
| EPS (TTM) | : | ₹ 17.2 |
| P/E (TTM) | : | 36.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHREE GANESH REMEDIES | 1.5% | -2.9% | 181.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
SHREE GANESH REMEDIES Revenues
[BOM: 540737]
| Y-o-Y | 45.26 % |
| 5 Yr CAGR | 27.17 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹71 Cr | 45.26 | |
| Mar2022 | ₹49 Cr | -100.00 | |
| Mar2021 | ₹5,842,558 Cr | 16,544,494.38 | |
| Mar2020 | ₹35 Cr | 29.54 | |
| Mar2019 | ₹27 Cr | - | |
SHREE GANESH REMEDIES Operating Profit
[BOM: 540737]
| Y-o-Y | 31.30 % |
| 5 Yr CAGR | 36.32 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹18 Cr | 31.30 | |
| Mar2022 | ₹14 Cr | -100.00 | |
| Mar2021 | ₹1,094,734 Cr | 12,521,161.80 | |
| Mar2020 | ₹8.74 Cr | 68.49 | |
| Mar2019 | ₹5.19 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -9.60 % |
| 5 Yr CAGR | 7.21 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 25.14% | -9.60 | |
| Mar2022 | 27.81% | 48.40 | |
| Mar2021 | 18.74% | -24.31 | |
| Mar2020 | 24.76% | 30.11 | |
| Mar2019 | 19.03% | - | |
SHREE GANESH REMEDIES Profit After Tax
[BOM: 540737]
| Y-o-Y | 37.37 % |
| 5 Yr CAGR | 30.03 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹13 Cr | 37.37 | |
| Mar2022 | ₹9.75 Cr | -100.00 | |
| Mar2021 | ₹962,453 Cr | 15,436,196.01 | |
| Mar2020 | ₹6.24 Cr | 33.03 | |
| Mar2019 | ₹4.69 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.37 % |
| 5 Yr CAGR | 1.67 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 18.87 % | 0.37 | |
| Mar2022 | 18.8 % | -5.39 | |
| Mar2021 | 19.87 % | 20.64 | |
| Mar2020 | 16.47 % | -6.74 | |
| Mar2019 | 17.66 % | - | |
SHREE GANESH REMEDIES Earnings Per Share (EPS)
[BOM: 540737]
| Y-o-Y | 21.86 % |
| 5 Yr CAGR | 18.27 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹14 | 21.86 | |
| Mar2022 | ₹11 | 14.46 | |
| Mar2021 | ₹9.75 | -9.13 | |
| Mar2020 | ₹11 | 54.39 | |
| Mar2019 | ₹6.95 | - | |
SHREE GANESH REMEDIES Return on Capital Employed (ROCE)
[BOM: 540737]
| Y-o-Y | -24.02 % |
| 5 Yr CAGR | -2.27 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 24.67% | -24.02 | |
| Mar2022 | 32.47% | 18.03 | |
| Mar2021 | 27.51% | -15.69 | |
| Mar2020 | 32.63% | 20.67 | |
| Mar2019 | 27.04% | - | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Current Share Price | : | ₹629.8 |
| Current MarketCap | : | ₹ 806.1 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 1.5% |
-2.9% |
181.8% |
| SENSEX | 1.3% |
2.6% |
24% |
SHREE GANESH REMEDIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SHREE GANESH REMEDIES Financials
How the annual revenues of SHREE GANESH REMEDIES have changed ?
The Revenues of SHREE GANESH REMEDIES have increased by 45.26% YoY .
How the Earnings per Share (EPS) of SHREE GANESH REMEDIES have changed?
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has increased by 21.86 % YoY .
Check out Intrinsic Value of Peers of SHREE GANESH REMEDIES
Compare Stock Analytics of Peers of SHREE GANESH REMEDIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
